The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dermatological Remedies Market Research Report 2024
Synopsis
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
The global Dermatological Remedies market was valued at US$ 17250 million in 2023 and is anticipated to reach US$ 30320 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological Remedies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Remedies.
Report Scope
The Dermatological Remedies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Remedies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Remedies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Remedies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Dermatology is a field of medicine that is engaged in the diagnosis, prevention, and treatment of various skin, nails, hair diseases, pigmentation, acne, wrinkles, psoriasis, and others.
The global Dermatological Remedies market was valued at US$ 17250 million in 2023 and is anticipated to reach US$ 30320 million by 2030, witnessing a CAGR of 8.4% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Dermatological Remedies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Remedies.
Report Scope
The Dermatological Remedies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Remedies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Remedies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy's
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
Anti-infectives
Corticosteroids
Anti Psoriasis
Anti-acne
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Remedies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatological Remedies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anti-infectives
1.2.3 Corticosteroids
1.2.4 Anti Psoriasis
1.2.5 Anti-acne
1.2.6 Others
1.3 Market by Application
1.3.1 Global Dermatological Remedies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological Remedies Market Perspective (2019-2030)
2.2 Dermatological Remedies Growth Trends by Region
2.2.1 Global Dermatological Remedies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dermatological Remedies Historic Market Size by Region (2019-2024)
2.2.3 Dermatological Remedies Forecasted Market Size by Region (2025-2030)
2.3 Dermatological Remedies Market Dynamics
2.3.1 Dermatological Remedies Industry Trends
2.3.2 Dermatological Remedies Market Drivers
2.3.3 Dermatological Remedies Market Challenges
2.3.4 Dermatological Remedies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatological Remedies Players by Revenue
3.1.1 Global Top Dermatological Remedies Players by Revenue (2019-2024)
3.1.2 Global Dermatological Remedies Revenue Market Share by Players (2019-2024)
3.2 Global Dermatological Remedies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatological Remedies Revenue
3.4 Global Dermatological Remedies Market Concentration Ratio
3.4.1 Global Dermatological Remedies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatological Remedies Revenue in 2023
3.5 Dermatological Remedies Key Players Head office and Area Served
3.6 Key Players Dermatological Remedies Product Solution and Service
3.7 Date of Enter into Dermatological Remedies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatological Remedies Breakdown Data by Type
4.1 Global Dermatological Remedies Historic Market Size by Type (2019-2024)
4.2 Global Dermatological Remedies Forecasted Market Size by Type (2025-2030)
5 Dermatological Remedies Breakdown Data by Application
5.1 Global Dermatological Remedies Historic Market Size by Application (2019-2024)
5.2 Global Dermatological Remedies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dermatological Remedies Market Size (2019-2030)
6.2 North America Dermatological Remedies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dermatological Remedies Market Size by Country (2019-2024)
6.4 North America Dermatological Remedies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatological Remedies Market Size (2019-2030)
7.2 Europe Dermatological Remedies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dermatological Remedies Market Size by Country (2019-2024)
7.4 Europe Dermatological Remedies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatological Remedies Market Size (2019-2030)
8.2 Asia-Pacific Dermatological Remedies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dermatological Remedies Market Size by Region (2019-2024)
8.4 Asia-Pacific Dermatological Remedies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatological Remedies Market Size (2019-2030)
9.2 Latin America Dermatological Remedies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dermatological Remedies Market Size by Country (2019-2024)
9.4 Latin America Dermatological Remedies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatological Remedies Market Size (2019-2030)
10.2 Middle East & Africa Dermatological Remedies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dermatological Remedies Market Size by Country (2019-2024)
10.4 Middle East & Africa Dermatological Remedies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Dermatological Remedies Introduction
11.1.4 Bayer Revenue in Dermatological Remedies Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Dermatological Remedies Introduction
11.2.4 GSK Revenue in Dermatological Remedies Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva Dermatological Remedies Introduction
11.3.4 Teva Revenue in Dermatological Remedies Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Dermatological Remedies Introduction
11.4.4 Johnson & Johnson Revenue in Dermatological Remedies Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Dermatological Remedies Introduction
11.5.4 Novartis Revenue in Dermatological Remedies Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Dermatological Remedies Introduction
11.6.4 Mylan Revenue in Dermatological Remedies Business (2019-2024)
11.6.5 Mylan Recent Development
11.7 Sun Pharmaceutical
11.7.1 Sun Pharmaceutical Company Detail
11.7.2 Sun Pharmaceutical Business Overview
11.7.3 Sun Pharmaceutical Dermatological Remedies Introduction
11.7.4 Sun Pharmaceutical Revenue in Dermatological Remedies Business (2019-2024)
11.7.5 Sun Pharmaceutical Recent Development
11.8 Aurobindo
11.8.1 Aurobindo Company Detail
11.8.2 Aurobindo Business Overview
11.8.3 Aurobindo Dermatological Remedies Introduction
11.8.4 Aurobindo Revenue in Dermatological Remedies Business (2019-2024)
11.8.5 Aurobindo Recent Development
11.9 Galderma
11.9.1 Galderma Company Detail
11.9.2 Galderma Business Overview
11.9.3 Galderma Dermatological Remedies Introduction
11.9.4 Galderma Revenue in Dermatological Remedies Business (2019-2024)
11.9.5 Galderma Recent Development
11.10 CR SANJIU
11.10.1 CR SANJIU Company Detail
11.10.2 CR SANJIU Business Overview
11.10.3 CR SANJIU Dermatological Remedies Introduction
11.10.4 CR SANJIU Revenue in Dermatological Remedies Business (2019-2024)
11.10.5 CR SANJIU Recent Development
11.11 Dr. Reddy's
11.11.1 Dr. Reddy's Company Detail
11.11.2 Dr. Reddy's Business Overview
11.11.3 Dr. Reddy's Dermatological Remedies Introduction
11.11.4 Dr. Reddy's Revenue in Dermatological Remedies Business (2019-2024)
11.11.5 Dr. Reddy's Recent Development
11.12 Lupin
11.12.1 Lupin Company Detail
11.12.2 Lupin Business Overview
11.12.3 Lupin Dermatological Remedies Introduction
11.12.4 Lupin Revenue in Dermatological Remedies Business (2019-2024)
11.12.5 Lupin Recent Development
11.13 Bausch Health
11.13.1 Bausch Health Company Detail
11.13.2 Bausch Health Business Overview
11.13.3 Bausch Health Dermatological Remedies Introduction
11.13.4 Bausch Health Revenue in Dermatological Remedies Business (2019-2024)
11.13.5 Bausch Health Recent Development
11.14 Cipla
11.14.1 Cipla Company Detail
11.14.2 Cipla Business Overview
11.14.3 Cipla Dermatological Remedies Introduction
11.14.4 Cipla Revenue in Dermatological Remedies Business (2019-2024)
11.14.5 Cipla Recent Development
11.15 Qilu Pharmaceutical
11.15.1 Qilu Pharmaceutical Company Detail
11.15.2 Qilu Pharmaceutical Business Overview
11.15.3 Qilu Pharmaceutical Dermatological Remedies Introduction
11.15.4 Qilu Pharmaceutical Revenue in Dermatological Remedies Business (2019-2024)
11.15.5 Qilu Pharmaceutical Recent Development
11.16 Almirall
11.16.1 Almirall Company Detail
11.16.2 Almirall Business Overview
11.16.3 Almirall Dermatological Remedies Introduction
11.16.4 Almirall Revenue in Dermatological Remedies Business (2019-2024)
11.16.5 Almirall Recent Development
11.17 Lingrui
11.17.1 Lingrui Company Detail
11.17.2 Lingrui Business Overview
11.17.3 Lingrui Dermatological Remedies Introduction
11.17.4 Lingrui Revenue in Dermatological Remedies Business (2019-2024)
11.17.5 Lingrui Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
